Children deserve simple, short, safe, and effective treatment for rifampicin-resistant tuberculosis

被引：3
|
作者：
Garcia-Prats, Anthony J. [1 ,2 ]
Hoddinott, Graeme [2 ]
Howell, Pauline [3 ]
Hughes, Jennifer [2 ]
Jean-Philippe, Patrick [4 ]
Kim, Soyeon [5 ]
Palmer, Megan [2 ]
Schaaf, H. Simon [2 ]
Seddon, James A. [2 ,6 ]
Svensson, Elin [7 ,8 ]
Hesseling, Anneke C. [2 ]
机构：
[1] Univ Wisconsin, Sch Med & Publ Hlth, Dept Pediat, Madison, WI 53705 USA
[2] Stellenbosch Univ, Fac Med & Hlth Sci, Desmond Tutu TB Ctr, Dept Paediatics & Child Hlth, Cape Town, South Africa
[3] Univ Witwatersrand, Sizwe Trop Dis Hosp, Dept Internal Med, Clin HIV Res Unit,Wits Hlth Consortium, Johannesburg, South Africa
[4] NIAID, NIH, Bethesda, MD USA
[5] Frontier Sci Fdn, Dept Biostat, Brookline, MA USA
[6] Imperial Coll London, Dept Infect Dis, London, England
[7] Uppsala Univ, Dept Pharm, Uppsala, Sweden
[8] Radboud Univ Nijmegen, Med Ctr, Res Inst Med Innovat, Dept Pharm, Nijmegen, Netherlands
来源：
LANCET INFECTIOUS DISEASES | 2023年 / 23卷 / 07期
基金：
美国国家卫生研究院;
关键词：
PRETOMANID;
D O I：
10.1016/S1473-3099(23)00349-3
中图分类号：
R51 [传染病];
学科分类号：
100401 ;
摘要：
引用
收藏
页数：3
相关论文
共 50 条
  • [1] RIFAMPICIN-RESISTANT TUBERCULOSIS
    WYNNE, BA
    GUPTA, S
    LANCET, 1995, 346 (8980): : 971 - 972
  • [2] Longevity of modified standard short treatment regimens for rifampicin-resistant tuberculosis
    Decroo, Tom
    Mesic, Anita
    Decuyper, Ine
    LANCET INFECTIOUS DISEASES, 2024, 24 (10): : 1069 - 1071
  • [3] Successful Treatment of Rifampicin-resistant Intraocular Tuberculosis
    Sharma, Kusum
    Bansal, Reema
    Sharma, Aman
    Gupta, Amod
    Fiorella, Paul D.
    OCULAR IMMUNOLOGY AND INFLAMMATION, 2015, 23 (01) : 93 - 96
  • [4] Pharmacokinetics and Safety of Clofazimine in Children With Rifampicin-Resistant Tuberculosis
    Hughes, Jennifer A.
    Solans, Belen P.
    Garcia-Prats, Anthony J.
    Draper, Heather R.
    Schaaf, H. Simon
    Nielsen, James C.
    Nortier, Elri
    Courtney, Ingrid
    Palmer, Megan
    van der Laan, Louvina
    Savic, Radojka M.
    Hesseling, Anneke C.
    JOURNAL OF INFECTIOUS DISEASES, 2025,
  • [5] Moxifloxacin Pharmacokinetics, Cardiac Safety, and Dosing for the Treatment of Rifampicin-Resistant Tuberculosis in Children
    Radtke, Kendra K.
    Hesseling, Anneke C.
    Winckler, J. L.
    Draper, Heather R.
    Solans, Belen P.
    Thee, Stephanie
    Wiesner, Lubbe
    van der Laan, Louvina E.
    Fourie, Barend
    Nielsen, James
    Schaaf, H. Simon
    Savic, Radojka M.
    Garcia-Prats, Anthony J.
    CLINICAL INFECTIOUS DISEASES, 2022, 74 (08) : 1372 - 1381
  • [6] Pharmacokinetics and cardiac safety of clofazimine in children with rifampicin-resistant tuberculosis
    Ali, Ali Mohamed
    P. Solans, Belen
    Hesseling, Anneke C.
    Winckler, Jana
    Schaaf, H. Simon
    Draper, Heather R.
    van der Laan, Louvina
    Hughes, Jennifer
    Fourie, Barend
    Nielsen, James
    Wiesner, Lubbe
    Garcia-Prats, Anthony J.
    Savic, Radojka M.
    Silverman, Jared A.
    ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2024, 68 (01)
  • [7] RIFAMPICIN-RESISTANT MYCOBACTERIUM-TUBERCULOSIS
    WELTMAN, AC
    RIGHI, SP
    DIFERDINANDO, GT
    JOVELL, RJ
    DRISCOLL, JR
    LANCET, 1995, 345 (8963): : 1513 - 1513
  • [8] Therapeutic choices in rifampicin-resistant tuberculosis
    Ganatra, Shashank
    Udwadia, Zarir
    Rodrigues, Camilla
    LANCET INFECTIOUS DISEASES, 2016, 16 (11): : 1220 - 1221
  • [9] Treatment regimens for rifampicin-resistant tuberculosis: highlighting a research gap
    Stagg, H. R.
    Hatherell, H-A.
    Lipman, M. C.
    Harris, R. J.
    Abubakar, I.
    INTERNATIONAL JOURNAL OF TUBERCULOSIS AND LUNG DISEASE, 2016, 20 (07) : 866 - 869
  • [10] Treatment of Rifampicin-Resistant Tuberculosis Disease and Infection in Children: Key Updates, Challenges and Opportunities
    Howell, Pauline
    Achar, Jay
    Huang, G. Khai Lin
    Mariandyshev, Andrei
    Schaaf, H. Simon
    Garcia-Prats, Anthony J.
    PATHOGENS, 2022, 11 (04):
12345